ArticleScientific reports2025
Integrative transcriptomic and single-cell analysis reveals mitochondrial-related gene biomarkers in heart failure with preserved ejection fraction.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome characterized by impaired diastolic function closely associated with mitochondrial dysfunction. This study aims to identify hub genes related to HFpEF and mitochondrial function, and to elucidate their potential mechanisms to offer new insights for therapeutic strategies. Differentially expressed genes (DEGs) from the GSE194151 dataset were intersected with mitochondrial-related genes (MRGs) to identify candidate genes. Machine learning techniques, including LASSO regression, SVM-RFE, and Boruta analysis, were used to select hub genes. A ceRNA regulatory network was constructed. Single-cell RNA sequencing data from GSE236585 were utilized to identify key cell types and analyze cell-cell interactions. Hub gene expression was validated using GSE236584, GSE180065, and RT-qPCR. We identified 336 DEGs and 1136 MRGs, with 9 intersecting candidate genes. Vwa8, Mthfd2, and Decr1 emerged as hub genes through machine learning techniques. Vwa8 localized to the cytoplasm, while Mthfd2 and Decr1 were nuclear. Functional enrichment analysis indicated that Decr1 is involved in the citric acid cycle and Parkinson's disease pathways, Mthfd2 in cardiac muscle contraction and ascorbate and aldolate metabolism, and Vwa8 in primary bile acid biosynthesis and pentose and gluconate interconversion pathways. Single-cell analysis highlighted fibroblasts as key cells with elevated hub gene expression in HFpEF. The ceRNA network included 2 mRNAs, 4 miRNAs, and 10 lncRNAs. Additionally, TF-mRNA analysis identified FOXL1 as a common regulator of Vwa8, Mthfd2, and Decr1. Hub genes showed significant diagnostic potential with high AUC values in both training and validation datasets. RT-qPCR confirmed their upregulation in HFpEF samples. This study identifies Vwa8, Mthfd2, and Decr1 as pivotal hub genes in HFpEF, elucidating their molecular mechanisms and potential as diagnostic biomarkers. These findings provide a valuable basis for developing targeted therapies for HFpEF, underscoring the importance of integrative bioinformatics and experimental approaches.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.